Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

ClinicalTrials.gov ID: NCT05263206

Public ClinicalTrials.gov record NCT05263206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Master Protocol of Two Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Studies to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Chronic Pruritus of Unknown Origin (CPUO)

Study identification

NCT ID
NCT05263206
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
284 participants

Conditions and interventions

Conditions

Interventions

  • Dupilumab Drug
  • Fexofenadine (loratadine if not available) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2022
Primary completion
Jun 1, 2027
Completion
Aug 24, 2027
Last update posted
Apr 8, 2026

2022 – 2027

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Kern Allergy and Medical Research- Site Number : 8400016 Bakersfield California 93301 Completed
Modena Allergy + Asthma- Site Number : 8400038 La Jolla California 92037 Recruiting
FoxHall Dermatology- Site Number : 8400042 Washington D.C. District of Columbia 20016 Recruiting
Palm Harbor Dermatology- Site Number : 8400024 Belleair Florida 32756 Recruiting
University of Miami Hospital- Site Number : 8400011 Miami Florida 33136 Recruiting
Skin Care Physicians of Georgia - Macon- Site Number : 8400030 Macon Georgia 31217 Recruiting
Aeroallergy Research Laboratory- Site Number : 8400036 Savannah Georgia 31406 Recruiting
Dawes Fretzin Clinical Research- Site Number : 8400007 Indianapolis Indiana 46256 Recruiting
Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400031 Louisville Kentucky 40241 Recruiting
Tulane University School of Medicine- Site Number : 8400045 New Orleans Louisiana 70112 Recruiting
Johns Hopkins Hospital- Site Number : 8400020 Baltimore Maryland 21287 Recruiting
The Asthma and Allergy Center- Site Number : 8400014 Bellevue Nebraska 68123 Recruiting
Mount Sinai - Union Square- Site Number : 8400034 New York New York 10003 Recruiting
AXIS Clinicals - Fargo- Site Number : 8400037 Fargo North Dakota 58103 Recruiting
Optima Research - Boardman- Site Number : 8400039 Boardman Ohio 44512 Recruiting
Columbia Dermatology & Aesthetics- Site Number : 8400047 Columbia South Carolina 29212 Recruiting
National Allergy and Asthma - North Charleston - Northside Drive- Site Number : 8400032 North Charleston South Carolina 29420 Recruiting
Complete Dermatology - Sugar Land- Site Number : 8400046 Sugar Land Texas 77479 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05263206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05263206 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →